In brief
The Ninth Circuit Court of Appeals has rejected Elizabeth Holmes’ appeal against her conviction for defrauding investors in her now-defunct blood-testing company, Theranos. Holmes, who was sentenced to more than 11 years in prison for conspiracy and multiple charges of wire fraud, argued that key evidence related to her ex-business partner Ramesh "Sunny" Balwani's responsibility for the company's financial misrepresentation should have been included in her trial. However, Judge Jacqueline H Nguyen, overseeing a three-judge panel, stated that the claims about Theranos' capability to conduct blood tests using just a finger prick were illusory: “nothing more than a mirage.”
The court's decision reaffirms the verdicts derived from a 2022 trial, where both Holmes and Balwani were convicted for misleading investors about Theranos' financial status and technology efficacy. Balwani was sentenced to over 12 years and also lost his appeal, both men challenged a court order to pay $452 million in restitution to victims, which the court upheld. Holmes’s claims that testimony from former employees was improper and that a government inspection report should not have been admitted were also dismissed by the court. Once valued at $9 billion, Theranos unceremoniously collapsed following revelations about its technological shortcomings in 2015. Holmes commenced her prison term in Texas in 2023. The fall of Elizabeth Holmes shares a cautionary tale in Silicon Valley's ambitious tech landscape, illustrating the precarious balance between innovation and accountability.
